Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2329-2331

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamilton, J. A.
Right arrow Articles by Jessup, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamilton, J. A.
Right arrow Articles by Jessup, W.
Related Collections
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2329-a.)
© 2000 American Heart Association, Inc.


Letters to the Editor

Oxidized LDL Can Promote Human Monocyte Survival

John A. Hamilton; Genevieve Whitty

Arthritis and Inflammation Research Centre, University of Melbourne, Department of Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia, 3050

Wendy Jessup

Heart Research Institute, Camperdown, New South Wales, Australia

To the Editor:

It is likely that in the early stages of atherosclerosis, circulating monocytes migrate into the subendothelial space, where they can mature into foam cells.1 2 3 4 5 There is in vivo and in vitro evidence for both foam cell death but also enhanced survival and growth.6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Human peripheral blood monocytes (>=95% pure) were obtained by countercurrent elutriation and usually cultured in minimal essential medium, {alpha}-modification ({alpha}-MEM)/1% pooled normal human serum (HS).23 24 The number of viable cells was measured by scraping the tissue culture surface and counting them in a hemocytometer with trypan blue exclusion or by propidium iodide staining (flow cytometry). Oxidized LDL (ox-LDL) was prepared as before.14

The number of viable monocytes declined when they were left untreated or treated with native LDL; this loss was reduced by both ox-LDL and acetylated LDL (ac-LDL; see the TableDown). A dose response for the ox-LDL effect is provided in the online FigureDown (please see http://atvb.ahajournals.org) and, as we found before with murine macrophages,14 doses of ox-LDL <=50 µg/mL generally promoted survival; at these survival-inducing doses, the cells spread on the tissue culture surface and remained attached. In contrast, at higher concentrations, viable cell numbers again declined. With different ox-LDL preparations, the effective survival dose response varied to some extent. The ability of ox-LDL to enhance human monocyte survival was confirmed with monocytes from 30 donors. We previously found that prior adherence of the monocytes for a short period under serum-free conditions, followed by culture in 1% HS, improved . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. Namgaladze, A. Kollas, and B. Brune
Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling
J. Lipid Res., January 1, 2008; 49(1): 58 - 65.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Namgaladze and B. Brune
Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2510 - 2516.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. A. Hamilton
Nondisposable materials, chronic inflammation, and adjuvant action
J. Leukoc. Biol., June 1, 2003; 73(6): 702 - 712.
[Abstract] [Full Text] [PDF]